We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LIVE:NASDAQLive Ventures Incorporated Analysis

Data as of 2026-06-17 - not real-time

$9.38

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Live Ventures is trading at $9.38, well below its 20‑day ($9.91), 50‑day ($11.78) and 200‑day ($14.69) simple moving averages, confirming a bearish technical backdrop. The RSI sits at 41, indicating neutral momentum, while the MACD line has just crossed above its signal, giving a slightly bullish signal amid an overall bearish trend. Volume is increasing and the stock is hovering near its support at $8.68, but the 30‑day volatility of ~117% and an extreme‑greed market sentiment suggest a very turbulent price environment.
Fundamentally, LIVE posted $438 M in revenue with a -3.8% YoY decline and razor‑thin profit margins (operating margin 1.95%, net margin 0.89%). The company reports a loss per share of -$1.09 and carries $232 M of debt versus $15 M of cash, resulting in a debt‑to‑equity ratio of 250%. However, the stock trades at a strikingly low price‑to‑book of 0.30 and price‑to‑sales of 0.07, and forward earnings are projected at $7.50 per share (forward PE 1.25). No dividend is paid, and cash flow generation is currently nil, underscoring substantial financial risk despite the deep valuation discount.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • High short‑term volatility and extreme‑greed market sentiment
  • Proximity to support with limited cash cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Deep discount to book and sales multiples
  • Projected forward EPS indicating potential earnings recovery
  • Heavy debt load limiting operational flexibility

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained undervaluation relative to assets
  • Cyclical exposure in home‑improvement retail that could benefit from economic recovery
  • Persistent leverage and lack of cash generation pose structural risk

Key Metrics & Analysis

Financial Health

Revenue Growth-3.80%
Profit Margin0.89%
P/E Ratio1.3
ROE4.26%
ROA2.74%
Debt/Equity250.15
P/B Ratio0.3

Technical Analysis

TrendBearish
RSI41.1
Support$8.68
Resistance$11.55
MA 20$9.91
MA 50$11.78
MA 200$14.69
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.84
Volatility116.89%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.